ArticlesDownstream September 21, 2023 High-concentration monoclonal antibody drugs: manufacturing challenges The growth in the formulation of drugs suitable for delivery by subcutaneous (Sub-C) injection... admin-element
ArticlesBioPharmaUpstream June 13, 2023 Pushing the Barriers in Next-Gen Antibody Development Continued development of new and next-generation antibodies is spurred by the increasing demand for more… admin-element
Articles March 30, 2016 A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications The Chinese hamster ovary (CHO) cell lines used for the production of recombinant therapeutic proteins... admin-element
ArticlesBioPharmaUpstream February 18, 2016 Antibody Production in Microbial Hosts The biopharmaceutical industry is growing exponentially, driven by an ever-increasing demand for monoclonal antibodies (mAbs)… admin-element